Patents by Inventor Jeffrey Lieberman

Jeffrey Lieberman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of secretin in the treatment of schizophrenia
    Publication number: 20070154534
    Abstract: The treatment of schizophrenia by administration of secretin to a patient in need thereof is disclosed.
    Type: Application
    Filed: March 11, 2004
    Publication date: July 5, 2007
    Inventors: Brian Sheitman, Jeffrey Lieberman, Michael Knable
  • Agranolocytosis screening procedure
    Patent number: 5223399
    Abstract: Certain patients undergoing clozapine drug therapy may be vulnerable to agranulocytosis. It has been found that agranulocytosis vulnerability is correlated with the presence of HLA antigens B38, DR4 and DQw3. Accordingly, a method is provided for detecting such patients, and an HLA kit is provided.
    Type: Grant
    Filed: March 19, 1991
    Date of Patent: June 29, 1993
    Assignees: Long Island Jewish Medical Center, Dana-Farber Cancer Institute
    Inventors: Jeffrey A. Lieberman, Edmond J. Yunis